Genesis Capital’s Post

"What Private Wants and What #HealthInnovation Ventures Must Show." FINN Chair Global Health and Purpose Gil Bashe presents at HITLAB. Gil underscores why too many people are focused on PE money ups and downs instead of where the money is focused and why. He taps into the Galen Growth | Insights You Can Trust data. It's the navigational guide for business development and venture capital. WATCH: https://lnkd.in/guhUBqXf

As private equity dealmakers gear up for a more promising 2024 in health care M&A, several key insights have emerged: 🔹 The bid-ask spread is finally closing, hinting at a more optimistic outlook for health care dealmaking this year. 🔹 Limited Partners (LPs) are emphasizing Distributed to Paid-In Capital (DPI), emphasizing the importance of returning money to investors amid slower dry powder deployment. 🔹 Regulatory scrutiny has increased, and is impacting both PE and strategics. 🔹 Many companies faced broken deal processes in 2023, leading to a cautious approach in the current market. 🔹 Co-investing is expected to persist as a strategy to bridge the bid-ask gap and generate returns for investors. Dealmakers should navigate regulatory complexities while simultaneously seizing the strategic investment avenues available within this 2024 health care M&A environment. Check out this article from Axios for more - https://lnkd.in/giUkjqmh #mergersandacquisitions #privateequity #healthtech #innovation #manda #venturecapital #foleyforward #garage2global Foley & Lardner LLP, Natasha Allen, Eric Chow, Brandee Diamond, Alicia Dorner, Lyman Thai, Tiaan De Nysschen, Alidad Vakili, André Thiollier

Growth firm backs emergency medicine A growth investment firm has invested in a company which provides emergency medicine services to private hospitals. Read more about this, and much more about private equity and venture capital, at: https://lnkd.in/gE-aPUTb #privateequity #venturecapital

Global Digital Health Investor Leaders in H1 2024 🌐💼 Over 1,600 #investors have participated in at least one funding deal in #DigitalHealth this year, with 50 making more than three investments in the first six months. This marks an increase from the previous year, when 47 investors reached this threshold, suggesting renewed confidence 📈. The top 🔝 6 investors in H1 2024 have participated in over 59 deals globally (not including accelerators and government grant programs) 🏆. General Catalyst leads the pack with 16 Digital Health deals, followed by Andreessen Horowitz and Khosla Ventures, each with 12 deals. Flare Capital Partners secured seven deals, while Insights Partners and Gaingels each made six. Download the full Galen Growth H1 2024 report (FOC) for deeper insights and analysis 📊🔍.

Top 25 Healthcare Investors in 2024. What a list to be a part of! Rami El Assal gave me an opportunity to bring my skillset to bear in his due diligence team, and along the way built with managing partners Stephen Thaddeus Connelly and Ryan Spitler, Ph.D. a Top 25 venture fund. For anyone out there looking to expand their skill set, I encourage you to take that leap of faith and aggressively pursue those opportunities that will get you to where you want to achieve in your professional career. Boutique was a fit for me because: - They had great deal flow and brought creativity to deals that allowed great deals to get done where conventional thinking wouldn't work - Deep scientific expertise. I get to learn about cutting-edge technology on a diligence team that writes academic books on the topics they invest in. - Their long-term support with investments gives me a front-row seat to witness companies and their founders grow into professional entrepreneurs and successful businesses - The people of Boutique have the right kind of ego. They know what they know, cold. They learn what they need to learn. Their approach has created opportunities for me to work with other prestigious venture firms because they benefit from Boutique's domain and deal expertise without the attitude. So, definitely make your list. Knock on doors... and don't take no for an answer. Even without a Top 25 nomination, supporting Boutique has continued to be a world-class experience. Many thanks to Boutique for this opportunity and my co-conspirator Craig Rochester for the pearls of wisdom he drops on our due diligence calls. #intellectualproperty #venturecapital

As the secondary market continues to grow, the healthcare sector seems to be left out of the conversation. As we conclude this series on VC Secondaries, Michael Boggs, a co-founded of Revelation Partners, provides his insights. Revelation manages over $1.5 billion, making them the largest dedicated provider targeting healthcare secondaries. Published on SecondaryLink. “Many of the companies we evaluate need to raise money. However, they typically have one or two investors that can no longer invest and support the company. We can serve as a catalyst to help bring together a financing. This helps the company solve their financing at the time we do our deal. As an example, we can price a primary round in conjunction with providing secondary liquidity thus catalyzing a financing event that de-risks the company. “ https://lnkd.in/gi7WnQHH

First #FiveForFriday of the year! Check it out! Healthcare Private Equity Market 2023: Year in Review and Outlook

Avesi Partners Closes $1.35B Fund for Healthcare and Business Services Investments - HIT Consultant #AvesiPartnersFundraising Avesi Partners, a healthcare investment firm, has successfully closed a $1.35 billion fund for investing in healthcare and business services. This significant fundraising effort will enable Avesi Partners to expand its portfolio and support innovative companies in the healthcare sector. #HealthcareInvestments #InvestmentFocus The fund will focus on investments in healthcare technology, digital health solutions, and other business services that have the potential to transform the healthcare industry. Avesi Partners aims to support companies that are driving innovation and improving patient care through their products and services. #DigitalHealth #StrategicPartnerships Avesi Partners will leverage strategic partnerships with industry leaders and experts to identify investment opportunities that ai.mediformatica.com #partners #busine #healthcare #collaboration #equity #market #privateequity #resources #richmond #digitalhealth #healthit #healthtech #healthcaretechnology @MediFormatica (https://buff.ly/4bBaoWO)

Marco Toni, Nicolas Wehrli, Gilles Pitschen and Pascal Hammerer have contributed to the Swiss chapter of the 2024 Healthcare M&A Chambers Global Practice Guide.   The guide provides the latest legal information on market trends, establishing healthcare start-ups, including early-stage financing and venture capital, IPOs and private sales, spin-offs, acquisition of listed companies, including stakebuilding, documentation, squeeze-out mechanisms, certain funds requirements and deal protection measures, regulatory requirements, including antitrust, foreign investment review and data privacy concerns, disclosure obligations, and duties of directors.   Click here to read the full chapter: https://lawand.tax/3RAAfah   #healthcare #lifesciences #Switzerland #lawandtax

How does a PE fund such as EQT add value to its portfolio companies? 💪 This was one of the questions I was asked during last week’s Annual Investor Meeting (AIM) where I participated in a panel facilitated by Michael Bauer with a focus on how collaboration drives value in healthcare @ EQT Group.   For Karo Healthcare, the answer has (at least) three components: 👉 First, EQT and PE ownership provides Karo access to people and capabilities that would otherwise not have been available to us. For example, though our company is not large (just north of EUR 500m in revenues), we have a Board of Directors that many much larger companies would envy with Sr. executive experience from large, renowned companies that are highly relevant for Karo’s platform in fast-moving consumer healthcare. The Board is active and engaged and “joined at the hip” with Management, which enables us to make decisions and move quickly. 👉 Second, the EQT platform provides scale and opens avenues that would not have been viable as a stand-alone entity. For example, we have grown Karo >4x over the last five years and focused the company on five core categories leveraging M&A (10+ M&A transactions), which has only been possible because of EQT’s excellent standing and solid banking relationships. With EQT backing us, we can think big. 👉 Third, EQT provides in-house expert support stretching from its deep Healthcare sector expertise and obvious capabilities in corporate finance and strategy to its teams providing support in the fields of digital, procurement, sustainability and so on.   A fourth component might be EQT’s relentless focus on driving performance and its credo that “everything in a company can always be improved at all times”! Thanks for a good AIM. We are not done building Karo yet! Onwards & upwards!  #smartchoices #everydayhealthcare